(2S,4R)-1-(tert-Butoxycarbonyl)-4-((2-(4-isopropoxyphenyl)benzofuro[3,2-d]pyrimidin-4-yl)oxy)pyrrolidine-2-carboxylic acid
97%
- Product Code: 36549
CAS:
1315326-78-3
| Molecular Weight: | 533.57 g./mol | Molecular Formula: | C₂₉H₃₁N₃O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30566066 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry and sealed |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of complex molecules, particularly in the development of targeted therapies. Its structure, featuring a benzofuropyrimidine core, makes it valuable in the design of inhibitors for specific enzymes or receptors involved in disease pathways. It is often employed in research focused on oncology, where its derivatives are explored for their potential to modulate cellular processes and inhibit tumor growth. Additionally, its chiral centers and functional groups allow for further chemical modifications, enabling the creation of analogs with optimized pharmacokinetic properties for drug development.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿1,143.00 |
+
-
|
| 5.000 | 10-20 days | ฿2,286.00 |
+
-
|
(2S,4R)-1-(tert-Butoxycarbonyl)-4-((2-(4-isopropoxyphenyl)benzofuro[3,2-d]pyrimidin-4-yl)oxy)pyrrolidine-2-carboxylic acid
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of complex molecules, particularly in the development of targeted therapies. Its structure, featuring a benzofuropyrimidine core, makes it valuable in the design of inhibitors for specific enzymes or receptors involved in disease pathways. It is often employed in research focused on oncology, where its derivatives are explored for their potential to modulate cellular processes and inhibit tumor growth. Additionally, its chiral centers and functional groups allow for further chemical modifications, enabling the creation of analogs with optimized pharmacokinetic properties for drug development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :